{"id":"W1985928174","doi":"10.1038/nature13121","title":"Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma","year":2014,"lang":"en","type":"article","venue":"Nature","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":910,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Melanoma; Cancer research; Vemurafenib; V600E; MEK inhibitor; Epidermal growth factor receptor; MAPK/ERK pathway; EGFR inhibitors; Selumetinib; Biology; Medicine; Oncogene; Kinase; Cancer; Mutation; Internal medicine; Cell cycle; Cell biology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null}